News | Artificial Intelligence | February 07, 2018

NEST Program Names ACR Data Science Institute AI Use Case as Demonstration Project

Designation boosts national efforts to improve medical imaging care using artificial intelligence

NEST Program Names ACR Data Science Institute AI Use Case as Demonstration Project

February 7, 2018 — A U.S. Food and Drug Administration (FDA)-funded program to speed safe and effective medical device technologies to market has chosen an ACR Data Science Institute (DSI) use case among its first demonstration projects.

The National Evaluation System for Health Technology Coordinating Center (NESTcc) selected the “Lung-RADS Assist: Advanced Radiology Guidance, Reporting and Monitoring” use case. The center supports timely, reliable and cost-effective evidence development regarding FDA medical device pre- and post-market requirements.

“We are proud that the NEST program recognizes the value of the ACR Data Science Institute’s groundbreaking work. The ACR DSI will employ our open framework, TOUCH-AI (Technology Oriented Use Cases for Healthcare Artificial Intelligence), to provide infrastructure for ongoing longitudinal AI algorithm verification pre- and post-FDA approval. This can help bring better medical care to patients more quickly,” said ACR DSI Chief Medical Officer Bibb Allen Jr., M.D., FACR.  

Lung-RADS Assist will determine the end-to-end workflow from deployment of an AI algorithm in a radiology reporting system through capture of performance metrics within a national registry. It will:

  • Utilize existing ACR technology to demonstrate the ability to collect validation data and perform local algorithm testing prior to market approval;
  • Utilize existing ACR technology to facilitate interoperability between reporting and AI vendors to generate standardized data in a real-world setting; and
  • Capture validation data and real-world events in a national registry to enable both facility-level and cross-facility reporting.

“The future of medical imaging is doctors harnessing the power of AI to enhance their decision making. New and existing technologies will provide greater detection and treatment by using all available data to improve patient -centered care. The ACR DSI provides a national foundation to move this process forward,” said Keith J. Dreyer, DO, Ph.D., FACR, ACR DSI chief science officer.

Use cases are clinical scenarios in which artificial intelligence (AI) use may improve care. Defining these cases is a first step in the creation of AI algorithms to answer primary clinical questions in each case. Medical imaging AI use case development is an initial focus of the ACR DSI. The DSI was launched in May 2017 to develop and use AI to help radiologists improve medical imaging care.

The first NESTcc demonstration projects will develop, verify and operationalize methods of evidence generation and data use. The projects will build out critical functions and processes to sustain the NEST program.

For more information: www.nestcc.org

 

Related Content

Treating lung cancer patients with proton therapy may help reduce the risk of radiation-induced heart diseases, suggests a new study from Penn Medicine. In a retrospective trial of more than 200 patients, mini-strokes were significantly less common among patients who underwent proton therapy versus conventional photon-based radiation therapy. Proton therapy patients also experienced fewer heart attacks.
News | Proton Therapy | October 25, 2020
October 25, 2020 — Treating lung cancer patients with prot...
Moffitt Cancer Center researchers are developing a noninvasive, accurate method to analyze a patient's tumor mutations and biomarkers to determine the best course of treatment.

Getty Images

News | Lung Imaging | October 19, 2020
October 19, 2020 — Personalized treatment options for patients with...
Newly released study results present a strong case for lung cancer screening in New Zealand — particularly for Māori whose mortality rates are between three and four times higher than other ethnic groups.

Image courtesy of Siemens Healthineers

News | Lung Imaging | September 30, 2020
September 30, 2020 — Newly released study results present a strong case for...
Lung and respiratory health pioneer paves way for more precise care of complex respiratory conditions
News | Artificial Intelligence | September 25, 2020
September 25, 2020 — VIDA Diagnostics, Inc. announced that it has received 510(k) clearance from the Food and Drug Ad
Philips Azurion Lung Edition supports high precision diagnosis and minimally invasive therapy in one room
News | Lung Imaging | September 21, 2020
September 21, 2020 — Philips introduced...
Diagnosing respiratory illness associated with vaping has always been challenging. Adding the spread of COVID-19 and the many similarities in symptoms makes it even more difficult. 

Getty Images

News | Lung Imaging | September 01, 2020
September 1, 2020 — Diagnosing respiratory illness associated with...
Smoking is strongly linked to lower use of cancer screening services by women, and more advanced disease once cancer is diagnosed, reveals research published in the online journal BMJ Open.

Getty Images

News | Lung Imaging | August 14, 2020
August 14, 2020 — Smoking is strongly linked to lower use of...